{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T02:45:56Z","timestamp":1769309156000,"version":"3.49.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:00:00Z","timestamp":1769212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:00:00Z","timestamp":1769212800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Familie Mehdorn Stiftung"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosurg Rev"],"DOI":"10.1007\/s10143-025-04063-2","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T01:11:28Z","timestamp":1769217088000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of azacitidine in meningiomas and explorative analyses of underlying molecular mechanisms"],"prefix":"10.1007","volume":"49","author":[{"given":"Valerie","family":"Abt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Stummer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volker","family":"Senner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Brokinkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorothee","family":"Spille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,24]]},"reference":[{"issue":"1","key":"4063_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-022-01329-0","volume":"14","author":"T Aumer","year":"2022","unstructured":"Aumer T, Gremmelmaier CB, Runtsch LS et al (2022) Comprehensive comparison between azacytidine and decitabine treatment in an acute myeloid leukemia cell line. Clin Epigenetics 14(1):113. https:\/\/doi.org\/10.1186\/s13148-022-01329-0","journal-title":"Clin Epigenetics"},{"issue":"2","key":"4063_CR2","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.12970","volume":"32","author":"AS Berghoff","year":"2022","unstructured":"Berghoff AS, Hielscher T, Ricken G et al (2022) Prognostic impact of genetic alterations and methylation classes in meningioma. Brain pathology (Zurich, Switzerland) 32(2):e12970. https:\/\/doi.org\/10.1111\/bpa.12970","journal-title":"Brain pathology (Zurich, Switzerland)"},{"issue":"10","key":"4063_CR3","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.18632\/oncotarget.1408","volume":"4","author":"A Borodovsky","year":"2013","unstructured":"Borodovsky A, Salmasi V, Turcan S et al (2013) 5-azacytidine reduces methylation, promotes differentiation and induces tumor regression in a patient-derived IDH1 mutant glioma xenograft. Oncotarget 4(10):1737\u20131747. https:\/\/doi.org\/10.18632\/oncotarget.1408","journal-title":"Oncotarget"},{"issue":"4","key":"4063_CR4","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1080\/10428190701882146","volume":"49","author":"G Borthakur","year":"2008","unstructured":"Borthakur G, Ahdab SE, Ravandi F et al (2008) Activity of decitabine in patients with myelodysplastic syndrome previously treated with azacitidine. Leuk Lymphoma 49(4):690\u2013695. https:\/\/doi.org\/10.1080\/10428190701882146","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"4063_CR5","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1093\/jnen\/nlx008","volume":"76","author":"C Boulagnon-Rombi","year":"2017","unstructured":"Boulagnon-Rombi C, Fleury C, Fichel C et al (2017) Immunohistochemical approach to the differential diagnosis of meningiomas and their mimics. J Neuropathol Exp Neurol 76(4):289\u2013298. https:\/\/doi.org\/10.1093\/jnen\/nlx008","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"4063_CR6","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1007\/s10143-022-01789-1","volume":"45","author":"J Canisius","year":"2022","unstructured":"Canisius J, Wagner A, Bunk EC et al (2022) Expression of decitabine-targeted oncogenes in meningiomas in vivo. Neurosurg Rev 45(4):2767\u20132775. https:\/\/doi.org\/10.1007\/s10143-022-01789-1","journal-title":"Neurosurg Rev"},{"issue":"5","key":"4063_CR7","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/s41588-022-01061-8","volume":"54","author":"A Choudhury","year":"2022","unstructured":"Choudhury A, Magill ST, Eaton CD et al (2022) Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities. Nat Genet 54(5):649\u2013659. https:\/\/doi.org\/10.1038\/s41588-022-01061-8","journal-title":"Nat Genet"},{"issue":"3","key":"4063_CR8","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/0005-2787(65)90046-8","volume":"108","author":"A Cih\u00e1k","year":"1965","unstructured":"Cih\u00e1k A, Vesel\u00fd J, Sorm F (1965) Incorporation of 5-azacytidine into liver ribonucleic acids of leukemic mice sensitive and resistant to 5-azacytidine. Biochim Biophys Acta 108(3):516\u2013518. https:\/\/doi.org\/10.1016\/0005-2787(65)90046-8","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"4063_CR9","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1093\/neuonc\/noab263","volume":"24","author":"M Da Costa Rosa","year":"2022","unstructured":"Da Costa Rosa M, Yamashita AS, Riggins GJ (2022) Evaluation of a DNA demethylating agent in combination with all-trans retinoic acid for IDH1-mutant gliomas. Neurooncol 24(5):711\u2013723. https:\/\/doi.org\/10.1093\/neuonc\/noab263","journal-title":"Neurooncol"},{"key":"4063_CR10","unstructured":"Dang D, Le M, Irmer T et al (2021) APEER: An Interactive Cloud Platform for Microscopists to Easily Deploy Deep Learning. Zenodo"},{"issue":"7","key":"4063_CR11","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1007\/s12094-019-02240-6","volume":"22","author":"A Das","year":"2020","unstructured":"Das A, Alshareef M, Henderson F et al (2020) Ganoderic acid A\/DM-induced NDRG2 over-expression suppresses high-grade meningioma growth. Clin Transl Oncol 22(7):1138\u20131145. https:\/\/doi.org\/10.1007\/s12094-019-02240-6","journal-title":"Clin Transl Oncol"},{"issue":"3","key":"4063_CR12","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1182\/blood-2015-01-621664","volume":"126","author":"H Dombret","year":"2015","unstructured":"Dombret H, Seymour JF, Butrym A et al (2015) International phase 3 study of Azacitidine vs conventional care regimens in older patients with newly diagnosed AML with 30% blasts. Blood 126(3):291\u2013299. https:\/\/doi.org\/10.1182\/blood-2015-01-621664","journal-title":"Blood"},{"issue":"5","key":"4063_CR13","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.3892\/or.2019.7074","volume":"41","author":"A Estekizadeh","year":"2019","unstructured":"Estekizadeh A, Land\u00e1zuri N, Pantalone MR et al (2019) 5?Azacytidine treatment results in nuclear exclusion of DNA methyltransferase?1, as well as reduced proliferation and invasion in human cytomegalovirus?infected glioblastoma cells. Oncol Rep 41(5):2927\u20132936. https:\/\/doi.org\/10.3892\/or.2019.7074","journal-title":"Oncol Rep"},{"issue":"11","key":"4063_CR14","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1093\/neuonc\/noab150","volume":"23","author":"R Goldbrunner","year":"2021","unstructured":"Goldbrunner R, Stavrinou P, Jenkinson MD et al (2021) EANO guideline on the diagnosis and management of meningiomas. Neuro-oncol 23(11):1821\u20131834. https:\/\/doi.org\/10.1093\/neuonc\/noab150","journal-title":"Neuro-oncol"},{"issue":"5","key":"4063_CR15","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1006\/jmbi.2001.4710","volume":"309","author":"H Gowher","year":"2001","unstructured":"Gowher H, Jeltsch A (2001) Enzymatic properties of recombinant Dnmt3a DNA methyltransferase from mouse: the enzyme modifies DNA in a non-processive manner and also methylates non-CpG correction of non-CpA sites. J Mol Biol 309(5):1201\u20131208. https:\/\/doi.org\/10.1006\/jmbi.2001.4710","journal-title":"J Mol Biol"},{"issue":"3","key":"4063_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017388","volume":"6","author":"S Hagemann","year":"2011","unstructured":"Hagemann S, Heil O, Lyko F et al (2011) Azacytidine and decitabine induce gene-specific and non-random DNA demethylation in human cancer cell lines. PLoS One 6(3):e17388. https:\/\/doi.org\/10.1371\/journal.pone.0017388","journal-title":"PLoS One"},{"issue":"2","key":"4063_CR17","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00280-019-03986-0","volume":"85","author":"T Higuchi","year":"2020","unstructured":"Higuchi T, Sugisawa N, Yamamoto J et al (2020) The combination of oral-recombinant methioninase and azacitidine arrests a chemotherapy-resistant osteosarcoma patient-derived orthotopic xenograft mouse model. Cancer Chemother Pharmacol 85(2):285\u2013291. https:\/\/doi.org\/10.1007\/s00280-019-03986-0","journal-title":"Cancer Chemother Pharmacol"},{"issue":"2","key":"4063_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009001","volume":"5","author":"PW Hollenbach","year":"2010","unstructured":"Hollenbach PW, Nguyen AN, Brady H et al (2010) A comparison of azacitidine and decitabine activities in acute myeloid leukemia cell lines. PLoS One 5(2):e9001. https:\/\/doi.org\/10.1371\/journal.pone.0009001","journal-title":"PLoS One"},{"issue":"49","key":"4063_CR19","doi-asserted-by":"publisher","first-page":"7862","DOI":"10.1038\/sj.onc.1207082","volume":"22","author":"K Horiguchi","year":"2003","unstructured":"Horiguchi K, Tomizawa Y, Tosaka M et al (2003) Epigenetic inactivation of RASSF1A candidate tumor suppressor gene at 3p21.3 in brain tumors. Oncogene 22(49):7862\u20137865. https:\/\/doi.org\/10.1038\/sj.onc.1207082","journal-title":"Oncogene"},{"issue":"12","key":"4063_CR20","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1093\/nar\/9.12.2933","volume":"9","author":"PA Jones","year":"1981","unstructured":"Jones PA, Taylor SM (1981) Hemimethylated duplex DNAs prepared from 5-azacytidine-treated cells. Nucleic Acids Res 9(12):2933\u20132947. https:\/\/doi.org\/10.1093\/nar\/9.12.2933","journal-title":"Nucleic Acids Res"},{"issue":"21","key":"4063_CR21","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1200\/JCO.2011.38.9429","volume":"30","author":"HM Kantarjian","year":"2012","unstructured":"Kantarjian HM, Thomas XG, Dmoszynska A et al (2012) Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia. J Clin Oncol 30(21):2670\u20132677. https:\/\/doi.org\/10.1200\/JCO.2011.38.9429","journal-title":"J Clin Oncol"},{"issue":"1","key":"4063_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-024-01143-2","volume":"14","author":"H Kantarjian","year":"2024","unstructured":"Kantarjian H, Borthakur G, Daver N et al (2024) Current status and research directions in acute myeloid leukemia. Blood Cancer J 14(1):163. https:\/\/doi.org\/10.1038\/s41408-024-01143-2","journal-title":"Blood Cancer J"},{"issue":"36","key":"4063_CR23","doi-asserted-by":"publisher","first-page":"e7975","DOI":"10.1097\/MD.0000000000007975","volume":"96","author":"T Katagiri","year":"2017","unstructured":"Katagiri T, Ushiki T, Masuko M et al (2017) Successful 5-azacytidine treatment of myeloid sarcoma and leukemia cutis associated with myelodysplastic syndrome: A case report and literature review. Medicine 96(36):e7975. https:\/\/doi.org\/10.1097\/MD.0000000000007975","journal-title":"Medicine"},{"issue":"12","key":"4063_CR24","doi-asserted-by":"publisher","first-page":"4175","DOI":"10.1007\/s00701-023-05848-4","volume":"165","author":"O Khanna","year":"2023","unstructured":"Khanna O, Barsouk A, Momin AA et al (2023) Predictors of recurrence after surgical resection of parafalcine and parasagittal meningiomas. Acta Neurochir 165(12):4175\u20134182. https:\/\/doi.org\/10.1007\/s00701-023-05848-4","journal-title":"Acta Neurochir"},{"issue":"5","key":"4063_CR25","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s00432-018-2600-1","volume":"144","author":"T Kratzsch","year":"2018","unstructured":"Kratzsch T, Kuhn SA, Joedicke A et al (2018) Treatment with 5-azacitidine delay growth of glioblastoma xenografts: a potential new treatment approach for glioblastomas. J Cancer Res Clin Oncol 144(5):809\u2013819. https:\/\/doi.org\/10.1007\/s00432-018-2600-1","journal-title":"J Cancer Res Clin Oncol"},{"issue":"7","key":"4063_CR26","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.jocn.2013.11.015","volume":"21","author":"RR Lall","year":"2014","unstructured":"Lall RR, Lall RR, Smith TR et al (2014) Delayed malignant transformation of petroclival meningioma to chondrosarcoma after stereotactic radiosurgery. J Clin Neurosci 21(7):1225\u20131228. https:\/\/doi.org\/10.1016\/j.jocn.2013.11.015","journal-title":"J Clin Neurosci"},{"issue":"11","key":"4063_CR27","first-page":"2760","volume":"30","author":"LH Li","year":"1970","unstructured":"Li LH, Olin EJ, Buskirk HH et al (1970) Cytotoxicity and mode of action of 5-azacytidine on L1210 leukemia. Cancer Res 30(11):2760\u20132769","journal-title":"Cancer Res"},{"issue":"4","key":"4063_CR28","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.humpath.2005.02.006","volume":"36","author":"Y Liu","year":"2005","unstructured":"Liu Y, Pang JC, Dong S et al (2005) Aberrant CpG island hypermethylation profile is associated with atypical and anaplastic meningiomas. Hum Pathol 36(4):416\u2013425. https:\/\/doi.org\/10.1016\/j.humpath.2005.02.006","journal-title":"Hum Pathol"},{"issue":"20","key":"4063_CR29","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1093\/jnci\/dji311","volume":"97","author":"F Lyko","year":"2005","unstructured":"Lyko F, Brown R (2005) DNA methyltransferase inhibitors and the development of epigenetic cancer therapies. J Natl Cancer Inst 97(20):1498\u20131506. https:\/\/doi.org\/10.1093\/jnci\/dji311","journal-title":"J Natl Cancer Inst"},{"issue":"34","key":"4063_CR30","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.1200\/JCO.21.00784","volume":"39","author":"SLN Maas","year":"2021","unstructured":"Maas SLN, Stichel D, Hielscher T et al (2021) Integrated molecular-morphologic meningioma classification: a multicenter retrospective analysis, retrospectively and prospectively validated. J Clin Oncol 39(34):3839\u20133852. https:\/\/doi.org\/10.1200\/JCO.21.00784","journal-title":"J Clin Oncol"},{"key":"4063_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2023.107040","volume":"127","author":"L Maurillo","year":"2023","unstructured":"Maurillo L, Spagnoli A, Candoni A et al (2023) Comparison between azacitidine and decitabine as front-line therapy in elderly acute myeloid leukemia patients not eligible for intensive chemotherapy. Leuk Res 127:107040. https:\/\/doi.org\/10.1016\/j.leukres.2023.107040","journal-title":"Leuk Res"},{"issue":"7874","key":"4063_CR32","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41586-021-03850-3","volume":"597","author":"F Nassiri","year":"2021","unstructured":"Nassiri F, Liu J, Patil V et al (2021) A clinically applicable integrative molecular classification of meningiomas. Nature 597(7874):119\u2013125. https:\/\/doi.org\/10.1038\/s41586-021-03850-3","journal-title":"Nature"},{"issue":"1","key":"4063_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15006-4","volume":"11","author":"A Nishiyama","year":"2020","unstructured":"Nishiyama A, Mulholland CB, Bultmann S et al (2020) Two distinct modes of DNMT1 recruitment ensure stable maintenance DNA methylation. Nat Commun 11(1):1222. https:\/\/doi.org\/10.1038\/s41467-020-15006-4","journal-title":"Nat Commun"},{"issue":"1","key":"4063_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11413-4","volume":"10","author":"T Oellerich","year":"2019","unstructured":"Oellerich T, Schneider C, Thomas D et al (2019) Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AML. Nat Commun 10(1):3475. https:\/\/doi.org\/10.1038\/s41467-019-11413-4","journal-title":"Nat Commun"},{"issue":"3","key":"4063_CR35","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/s0092-8674(00)81656-6","volume":"99","author":"M Okano","year":"1999","unstructured":"Okano M, Bell DW, Haber DA et al (1999) DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99(3):247\u2013257. https:\/\/doi.org\/10.1016\/s0092-8674(00)81656-6","journal-title":"Cell"},{"key":"4063_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15113002","author":"N Premnath","year":"2023","unstructured":"Premnath N, Madanat YF (2023) Paradigm shift in the management of acute myeloid leukemia-approved options in 2023. Cancers. https:\/\/doi.org\/10.3390\/cancers15113002","journal-title":"Cancers"},{"issue":"3","key":"4063_CR37","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1182\/blood-2008-02-140038","volume":"113","author":"T Qin","year":"2009","unstructured":"Qin T, Jelinek J, Si J et al (2009) Mechanisms of resistance to 5-aza-2\u2019-deoxycytidine in human cancer cell lines. Blood 113(3):659\u2013667. https:\/\/doi.org\/10.1182\/blood-2008-02-140038","journal-title":"Blood"},{"issue":"5","key":"4063_CR38","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/S1470-2045(17)30155-9","volume":"18","author":"F Sahm","year":"2017","unstructured":"Sahm F, Schrimpf D, Stichel D et al (2017) DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis. Lancet Oncol 18(5):682\u2013694. https:\/\/doi.org\/10.1016\/S1470-2045(17)30155-9","journal-title":"Lancet Oncol"},{"issue":"2","key":"4063_CR39","doi-asserted-by":"publisher","first-page":"133","DOI":"10.5114\/fn.2020.96970","volume":"58","author":"S Samal","year":"2020","unstructured":"Samal S, Patnaik A, Sahu F et al (2020) Altered expression of epigenetic modifiers EZH2, H3K27me3, and DNA methyltransferases in meningiomas - prognostic biomarkers for routine practice. Folia Neuropathol 58(2):133\u2013142. https:\/\/doi.org\/10.5114\/fn.2020.96970","journal-title":"Folia Neuropathol"},{"key":"4063_CR40","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6640597","volume":"2021","author":"K Sato","year":"2021","unstructured":"Sato K, Tsukada N, Inamura J et al (2021) Successful treatment of myeloid sarcoma in an elderly patient with myelodysplastic syndrome with reduced-dose azacitidine. Case Rep Hematol 2021:6640597. https:\/\/doi.org\/10.1155\/2021\/6640597","journal-title":"Case Rep Hematol"},{"issue":"20","key":"4063_CR41","doi-asserted-by":"publisher","first-page":"8127","DOI":"10.1158\/0008-5472.CAN-09-0458","volume":"69","author":"M Schaefer","year":"2009","unstructured":"Schaefer M, Hagemann S, Hanna K et al (2009) Azacytidine inhibits RNA methylation at DNMT2 target sites in human cancer cell lines. Cancer Res 69(20):8127\u20138132. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-0458","journal-title":"Cancer Res"},{"issue":"6","key":"4063_CR42","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.3171\/2020.4.JNS20412","volume":"134","author":"DC Spille","year":"2021","unstructured":"Spille DC, Hess K, Bormann E et al (2021) Risk of tumor recurrence in intracranial meningiomas: comparative analyses of the predictive value of the postoperative tumor volume and the Simpson classification. J Neurosurg 134(6):1764\u20131771. https:\/\/doi.org\/10.3171\/2020.4.JNS20412","journal-title":"J Neurosurg"},{"issue":"1","key":"4063_CR43","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s11060-023-04379-3","volume":"164","author":"DC Spille","year":"2023","unstructured":"Spille DC, Thomas C, Wagner A et al (2023) Molecular predictors for decitabine efficacy in meningiomas - a pilot study. J Neurooncol 164(1):97\u2013105. https:\/\/doi.org\/10.1007\/s11060-023-04379-3","journal-title":"J Neurooncol"},{"issue":"3","key":"4063_CR44","doi-asserted-by":"publisher","first-page":"845","DOI":"10.3171\/2020.7.JNS193097","volume":"135","author":"L St\u00f6gbauer","year":"2021","unstructured":"St\u00f6gbauer L, Thomas C, Wagner A et al (2021) Efficacy of decitabine in malignant meningioma cells: relation to promoter demethylation of distinct tumor suppressor and oncogenes and independence from TERT. J Neurosurg 135(3):845\u2013854. https:\/\/doi.org\/10.3171\/2020.7.JNS193097","journal-title":"J Neurosurg"},{"key":"4063_CR45","doi-asserted-by":"publisher","unstructured":"Sun M, Orpilla J, Contreras E et al (2022) EXTH-87. Decitabine potentiates meningioma immunotherapy targeting NY-ESO-1. Neuro-oncology 24(Supplement_7): vii229-vii229. https:\/\/doi.org\/10.1093\/neuonc\/noac209.885","DOI":"10.1093\/neuonc\/noac209.885"},{"issue":"5","key":"4063_CR46","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.3892\/ijo.2015.2906","volume":"46","author":"M Tarnowski","year":"2015","unstructured":"Tarnowski M, Tkacz M, Czerewaty M et al (2015) 5?Azacytidine inhibits human rhabdomyosarcoma cell growth by downregulating insulin?like growth factor 2 expression and reactivating the H19 gene product miR?675, which negatively affects insulin?like growth factors and insulin signaling. Int J Oncol 46(5):2241\u20132250. https:\/\/doi.org\/10.3892\/ijo.2015.2906","journal-title":"Int J Oncol"},{"key":"4063_CR47","doi-asserted-by":"publisher","first-page":"e99","DOI":"10.1016\/j.wneu.2022.02.108","volume":"162","author":"PD Tatman","year":"2022","unstructured":"Tatman PD, Wroblewski TH, Fringuello AR et al (2022) Targeting DNA methyl transferases with decitabine in cultured meningiomas. World Neurosurg 162:e99\u2013e119. https:\/\/doi.org\/10.1016\/j.wneu.2022.02.108","journal-title":"World Neurosurg"},{"issue":"3","key":"4063_CR48","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.gendis.2022.06.001","volume":"10","author":"T Wang","year":"2023","unstructured":"Wang T, Liu P, Yang J (2023) Targeting SAMHD1: to overcome multiple anti-cancer drugs resistance in hematological malignancies. Genes Dis 10(3):891\u2013900. https:\/\/doi.org\/10.1016\/j.gendis.2022.06.001","journal-title":"Genes Dis"},{"issue":"10","key":"4063_CR49","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1093\/neuonc\/noae082","volume":"26","author":"JZ Wang","year":"2024","unstructured":"Wang JZ, Landry AP, Raleigh DR et al (2024) Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients. Neuro Oncol 26(10):1742\u20131780. https:\/\/doi.org\/10.1093\/neuonc\/noae082","journal-title":"Neuro Oncol"},{"issue":"37","key":"4063_CR50","doi-asserted-by":"publisher","first-page":"12984","DOI":"10.1002\/anie.201904794","volume":"58","author":"TM Wildenhof","year":"2019","unstructured":"Wildenhof TM, Schiffers S, Traube FR et al (2019) Influencing epigenetic information with a hydrolytically stable carbocyclic 5-aza-2\u2019-deoxycytidine. Angew Chem Int Ed Engl 58(37):12984\u201312987. https:\/\/doi.org\/10.1002\/anie.201904794","journal-title":"Angew Chem Int Ed Engl"}],"container-title":["Neurosurgical Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-025-04063-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10143-025-04063-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-025-04063-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T14:02:15Z","timestamp":1769263335000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10143-025-04063-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,24]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4063"],"URL":"https:\/\/doi.org\/10.1007\/s10143-025-04063-2","relation":{},"ISSN":["1437-2320"],"issn-type":[{"value":"1437-2320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,24]]},"assertion":[{"value":"16 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the local ethics committee (\n                      2022-014-f-S; Ethikkommission der \u00c4rztekammer Westfalen Lippe und der Universit\u00e4t M\u00fcnster\n                      ).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"155"}}